Claude Code's been what everyone's talking about lately. Anthropic is relentlessly updating it with new features, to the point where it's genuinely difficult to keep up with! Of course, this also ...

Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.